Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajinder Kumar Suri

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine: X|August 3, 2023
Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 reportRajinder Kumar Suri, Christina Liu, Aila Marini
Vaccine|March 10, 2015
Vaccines, our shared responsibilitySonia Pagliusi, Rishabh Jain, Rajinder Kumar Suri, et al.
Vaccine|November 5, 2022
Sustainable vaccine manufacturing in low- and middle-Income countriesBenoit Hayman, Rajinder Kumar Suri, Matthew Downham
Vaccine|November 2, 2025
Adaptive clinical trial designs for rapid vaccine development: Developing country vaccine manufacturers' perspectiveManish Mahajan, Laura B Martin, Kumar Gaurav, et al.
Vaccine|May 16, 2022
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General MeetingRajinder Kumar Suri, Benoit Hayman, Sai D Prasad, et al.
The Lancet. Infectious Diseases|March 3, 2022
Accelerating research and development of new vaccines against tuberculosis: a global roadmapFrank Cobelens, Rajinder Kumar Suri, Michelle Helinski, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine: X|August 3, 2023
Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 reportRajinder Kumar Suri, Christina Liu, Aila Marini
Vaccine|March 10, 2015
Vaccines, our shared responsibilitySonia Pagliusi, Rishabh Jain, Rajinder Kumar Suri, et al.
Vaccine|November 5, 2022
Sustainable vaccine manufacturing in low- and middle-Income countriesBenoit Hayman, Rajinder Kumar Suri, Matthew Downham
Vaccine|November 2, 2025
Adaptive clinical trial designs for rapid vaccine development: Developing country vaccine manufacturers' perspectiveManish Mahajan, Laura B Martin, Kumar Gaurav, et al.
Vaccine|May 16, 2022
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General MeetingRajinder Kumar Suri, Benoit Hayman, Sai D Prasad, et al.
The Lancet. Infectious Diseases|March 3, 2022
Accelerating research and development of new vaccines against tuberculosis: a global roadmapFrank Cobelens, Rajinder Kumar Suri, Michelle Helinski, et al.
Pageof 1